| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | testosterone 16-alpha-hydroxylase activity | 2.24e-06 | 4 | 166 | 3 | GO:0008390 | |
| GeneOntologyMolecularFunction | testosterone 6-beta-hydroxylase activity | 5.57e-06 | 5 | 166 | 3 | GO:0050649 | |
| GeneOntologyMolecularFunction | vitamin D 23-hydroxylase activity | 5.57e-06 | 5 | 166 | 3 | GO:0062179 | |
| GeneOntologyMolecularFunction | 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity | 5.57e-06 | 5 | 166 | 3 | GO:0062181 | |
| GeneOntologyMolecularFunction | microtubule binding | DCDC1 EML4 EML6 DYSF MAP10 TUBGCP6 NEFH NF1 RMDN1 ABRAXAS1 MACF1 DYNC1I1 | 1.07e-05 | 308 | 166 | 12 | GO:0008017 |
| GeneOntologyMolecularFunction | vitamin D3 25-hydroxylase activity | 1.11e-05 | 6 | 166 | 3 | GO:0030343 | |
| GeneOntologyMolecularFunction | vitamin D 24-hydroxylase activity | 1.11e-05 | 6 | 166 | 3 | GO:0070576 | |
| GeneOntologyMolecularFunction | vitamin D 25-hydroxylase activity | 1.93e-05 | 7 | 166 | 3 | GO:0070643 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor | 3.06e-05 | 8 | 166 | 3 | GO:0033695 | |
| GeneOntologyMolecularFunction | caffeine oxidase activity | 3.06e-05 | 8 | 166 | 3 | GO:0034875 | |
| GeneOntologyMolecularFunction | estrogen 2-hydroxylase activity | 3.06e-05 | 8 | 166 | 3 | GO:0101021 | |
| GeneOntologyMolecularFunction | estrogen 16-alpha-hydroxylase activity | 8.86e-05 | 11 | 166 | 3 | GO:0101020 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | DCDC1 SYNM MYO9B EML4 EML6 DYSF MAP10 ABLIM3 TUBGCP6 SPTBN4 SPTBN5 NEFH NF1 DLC1 LMO7 RMDN1 ABRAXAS1 SYNE2 MACF1 SNTA1 DYNC1I1 FRMD3 | 1.18e-04 | 1099 | 166 | 22 | GO:0008092 |
| GeneOntologyMolecularFunction | GTPase activator activity | MYO9B TBC1D8B RGS7 RGS12 RGS8 NF1 DLC1 TBC1D14 ARHGAP21 ARAP1 | 1.18e-04 | 279 | 166 | 10 | GO:0005096 |
| GeneOntologyMolecularFunction | retinoic acid 4-hydroxylase activity | 1.92e-04 | 14 | 166 | 3 | GO:0008401 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups | 2.39e-04 | 15 | 166 | 3 | GO:0016725 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 2.46e-04 | 37 | 166 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | tubulin binding | DCDC1 EML4 EML6 DYSF MAP10 TUBGCP6 NEFH NF1 RMDN1 ABRAXAS1 MACF1 DYNC1I1 | 2.52e-04 | 428 | 166 | 12 | GO:0015631 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | IQSEC3 MYO9B TBC1D8B RGS7 RGS12 RGS8 NF1 DLC1 SBF1 TBC1D14 HERC2 ARHGAP21 ARAP1 | 3.30e-04 | 507 | 166 | 13 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | IQSEC3 MYO9B TBC1D8B RGS7 RGS12 RGS8 NF1 DLC1 SBF1 TBC1D14 HERC2 ARHGAP21 ARAP1 | 3.30e-04 | 507 | 166 | 13 | GO:0030695 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 4.20e-04 | 18 | 166 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | high-affinity L-glutamate transmembrane transporter activity | 6.76e-04 | 5 | 166 | 2 | GO:0005314 | |
| GeneOntologyMolecularFunction | glutamate:sodium symporter activity | 6.76e-04 | 5 | 166 | 2 | GO:0015501 | |
| GeneOntologyMolecularFunction | peptide hormone binding | 1.13e-03 | 55 | 166 | 4 | GO:0017046 | |
| GeneOntologyMolecularFunction | enzyme activator activity | WDR4 MYO9B GPRC5A TBC1D8B RGS7 RGS12 MMP24 RGS8 NF1 DLC1 TBC1D14 CDC20 ARHGAP21 ARAP1 | 1.19e-03 | 656 | 166 | 14 | GO:0008047 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.59e-03 | 28 | 166 | 3 | GO:0051959 | |
| GeneOntologyBiologicalProcess | vesicle cargo loading | 4.10e-07 | 36 | 167 | 6 | GO:0035459 | |
| GeneOntologyBiologicalProcess | alkaloid catabolic process | 5.15e-06 | 5 | 167 | 3 | GO:0009822 | |
| GeneOntologyBiologicalProcess | Golgi vesicle transport | CTAGE9 MIA3 CTAGE6 COG8 EXOC8 SLC30A6 CTAGE8 TBC1D14 CTAGE15 MACF1 EXOC1 CTAGE4 | 2.15e-05 | 339 | 167 | 12 | GO:0048193 |
| GeneOntologyBiologicalProcess | L-glutamate import | 3.43e-05 | 46 | 167 | 5 | GO:0051938 | |
| GeneOntologyBiologicalProcess | alkaloid metabolic process | 4.23e-05 | 9 | 167 | 3 | GO:0009820 | |
| GeneOntologyBiologicalProcess | lipid hydroxylation | 4.23e-05 | 9 | 167 | 3 | GO:0002933 | |
| GeneOntologyBiologicalProcess | positive regulation of uterine smooth muscle relaxation | 6.52e-05 | 2 | 167 | 2 | GO:1900721 | |
| GeneOntologyBiologicalProcess | regulation of uterine smooth muscle relaxation | 6.52e-05 | 2 | 167 | 2 | GO:1900719 | |
| GeneOntologyBiologicalProcess | uterine smooth muscle relaxation | 6.52e-05 | 2 | 167 | 2 | GO:0044558 | |
| GeneOntologyBiologicalProcess | oxidative demethylation | 1.09e-04 | 12 | 167 | 3 | GO:0070989 | |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 1.55e-04 | 99 | 167 | 6 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 1.64e-04 | 100 | 167 | 6 | GO:0045103 | |
| GeneOntologyBiologicalProcess | positive regulation of relaxation of smooth muscle | 1.94e-04 | 3 | 167 | 2 | GO:1901082 | |
| GeneOntologyBiologicalProcess | tight junction disassembly | 1.94e-04 | 3 | 167 | 2 | GO:1905071 | |
| GeneOntologyBiologicalProcess | positive regulation of tight junction disassembly | 1.94e-04 | 3 | 167 | 2 | GO:1905075 | |
| GeneOntologyBiologicalProcess | regulation of tight junction disassembly | 1.94e-04 | 3 | 167 | 2 | GO:1905073 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | EML4 DYSF MAP10 KIAA0753 DNAH1 TUBGCP6 NEFH RMDN1 ABRAXAS1 DNAH17 SYNE2 PAX6 CDC20 DYNC1H1 MOS BBOF1 | 2.57e-04 | 720 | 167 | 16 | GO:0000226 |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 1.09e-06 | 42 | 170 | 6 | GO:0070971 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRT26 KRT16 DCDC1 NCKAP1 SYNM MYO9B EML4 EML6 TPGS2 DYSF MAP10 DNAH1 TUBGCP6 SPTBN4 NEFH DLC1 RMDN1 DNAH17 MACF1 DYNC1H1 DYNC1I1 | 1.38e-05 | 899 | 170 | 21 | GO:0099513 |
| GeneOntologyCellularComponent | supramolecular fiber | KRT26 KRT16 DCDC1 NCKAP1 SYNM MYO9B EML4 EML6 TPGS2 DYSF MAP10 RYR2 DNAH1 TUBGCP6 SPTBN4 NEFH DLC1 RMDN1 DNAH17 SYNE2 MACF1 DYNC1H1 DYNC1I1 | 8.75e-05 | 1179 | 170 | 23 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KRT26 KRT16 DCDC1 NCKAP1 SYNM MYO9B EML4 EML6 TPGS2 DYSF MAP10 RYR2 DNAH1 TUBGCP6 SPTBN4 NEFH DLC1 RMDN1 DNAH17 SYNE2 MACF1 DYNC1H1 DYNC1I1 | 9.68e-05 | 1187 | 170 | 23 | GO:0099081 |
| GeneOntologyCellularComponent | microtubule | DCDC1 EML4 EML6 TPGS2 DYSF MAP10 DNAH1 TUBGCP6 RMDN1 DNAH17 MACF1 DYNC1H1 DYNC1I1 | 4.34e-04 | 533 | 170 | 13 | GO:0005874 |
| Domain | Cyt_P450_E_grp-II | 6.21e-06 | 5 | 161 | 3 | IPR002402 | |
| Domain | Cyt_P450_E_CYP3A | 1.23e-05 | 6 | 161 | 3 | IPR008072 | |
| Domain | WD40_repeat | WDR4 EML4 EML6 WSB2 WDFY4 ERCC8 MIOS HERC2 MAPKBP1 CDC20 DYNC1I1 | 2.47e-05 | 272 | 161 | 11 | IPR001680 |
| Domain | WD_REPEATS_1 | WDR4 EML4 EML6 WSB2 WDFY4 ERCC8 MIOS HERC2 MAPKBP1 CDC20 DYNC1I1 | 3.02e-05 | 278 | 161 | 11 | PS00678 |
| Domain | WD_REPEATS_2 | WDR4 EML4 EML6 WSB2 WDFY4 ERCC8 MIOS HERC2 MAPKBP1 CDC20 DYNC1I1 | 3.12e-05 | 279 | 161 | 11 | PS50082 |
| Domain | WD_REPEATS_REGION | WDR4 EML4 EML6 WSB2 WDFY4 ERCC8 MIOS HERC2 MAPKBP1 CDC20 DYNC1I1 | 3.12e-05 | 279 | 161 | 11 | PS50294 |
| Domain | Spectrin | 4.15e-05 | 23 | 161 | 4 | PF00435 | |
| Domain | ACTININ_2 | 4.15e-05 | 23 | 161 | 4 | PS00020 | |
| Domain | ACTININ_1 | 4.15e-05 | 23 | 161 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 4.15e-05 | 23 | 161 | 4 | IPR001589 | |
| Domain | Spectrin_repeat | 1.07e-04 | 29 | 161 | 4 | IPR002017 | |
| Domain | WD40 | 1.14e-04 | 268 | 161 | 10 | SM00320 | |
| Domain | SPEC | 1.58e-04 | 32 | 161 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.58e-04 | 32 | 161 | 4 | IPR018159 | |
| Domain | CH | 2.43e-04 | 65 | 161 | 5 | SM00033 | |
| Domain | WD40_repeat_dom | 2.61e-04 | 297 | 161 | 10 | IPR017986 | |
| Domain | PH_dom-like | CDC42BPG IQSEC3 WDFY4 RGS12 EXOC8 SPTBN4 SPTBN5 SBF1 ARHGAP21 SNTA1 ARAP1 FRMD3 | 3.32e-04 | 426 | 161 | 12 | IPR011993 |
| Domain | CH | 3.45e-04 | 70 | 161 | 5 | PF00307 | |
| Domain | - | 3.68e-04 | 71 | 161 | 5 | 1.10.418.10 | |
| Domain | CH | 4.19e-04 | 73 | 161 | 5 | PS50021 | |
| Domain | WD40 | 4.22e-04 | 259 | 161 | 9 | PF00400 | |
| Domain | CH-domain | 4.75e-04 | 75 | 161 | 5 | IPR001715 | |
| Domain | - | 6.40e-04 | 333 | 161 | 10 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 6.70e-04 | 335 | 161 | 10 | IPR015943 | |
| Domain | PH | CDC42BPG IQSEC3 EXOC8 SPTBN4 SPTBN5 SBF1 ARHGAP21 SNTA1 ARAP1 | 7.02e-04 | 278 | 161 | 9 | SM00233 |
| Domain | PH_DOMAIN | CDC42BPG IQSEC3 EXOC8 SPTBN4 SPTBN5 SBF1 ARHGAP21 SNTA1 ARAP1 | 7.20e-04 | 279 | 161 | 9 | PS50003 |
| Domain | PH_domain | CDC42BPG IQSEC3 EXOC8 SPTBN4 SPTBN5 SBF1 ARHGAP21 SNTA1 ARAP1 | 7.39e-04 | 280 | 161 | 9 | IPR001849 |
| Domain | PH | 8.51e-04 | 229 | 161 | 8 | PF00169 | |
| Domain | - | 8.58e-04 | 22 | 161 | 3 | 1.10.196.10 | |
| Domain | RGS_subdom1 | 8.58e-04 | 22 | 161 | 3 | IPR024066 | |
| Domain | Rho_GTPase_activation_prot | 9.85e-04 | 88 | 161 | 5 | IPR008936 | |
| Domain | HELP | 1.08e-03 | 6 | 161 | 2 | PF03451 | |
| Domain | HELP | 1.08e-03 | 6 | 161 | 2 | IPR005108 | |
| Domain | NA_DICARBOXYL_SYMP_1 | 1.51e-03 | 7 | 161 | 2 | PS00713 | |
| Domain | NA_DICARBOXYL_SYMP_2 | 1.51e-03 | 7 | 161 | 2 | PS00714 | |
| Domain | SDF | 1.51e-03 | 7 | 161 | 2 | PF00375 | |
| Domain | - | 1.51e-03 | 7 | 161 | 2 | 1.10.3860.10 | |
| Domain | Na-dicarboxylate_symporter | 1.51e-03 | 7 | 161 | 2 | IPR001991 | |
| Domain | Na-dicarboxylate_symporter_CS | 1.51e-03 | 7 | 161 | 2 | IPR018107 | |
| Pathway | BIOCARTA_ACETAMINOPHEN_PATHWAY | 4.05e-05 | 8 | 129 | 3 | MM1547 | |
| Pubmed | GPC1 IQSEC3 PDE1C KRT16 NCKAP1 PRR36 WFS1 PLD3 PFKP ABLIM3 SLC1A3 NDUFS8 SPTBN4 NEFH NF1 SBF1 LMO7 AJM1 MIOS PRKAR1A MACF1 EXOC1 ARHGAP21 SNTA1 DYNC1H1 DYNC1I1 | 8.15e-09 | 1431 | 170 | 26 | 37142655 | |
| Pubmed | 1.15e-07 | 3 | 170 | 3 | 23846873 | ||
| Pubmed | 1.15e-07 | 3 | 170 | 3 | 12147261 | ||
| Pubmed | Mouse liver cytochrome P-450 (P-450IIIAM1): its cDNA cloning and inducibility by dexamethasone. | 1.15e-07 | 3 | 170 | 3 | 1339292 | |
| Pubmed | Predominantly neuronal expression of cytochrome P450 isoforms CYP3A11 and CYP3A13 in mouse brain. | 1.15e-07 | 3 | 170 | 3 | 12617959 | |
| Pubmed | 1.15e-07 | 3 | 170 | 3 | 11726664 | ||
| Pubmed | High fat diet induced obesity is mitigated in Cyp3a-null female mice. | 1.15e-07 | 3 | 170 | 3 | 29738703 | |
| Pubmed | A novel female-specific member of the CYP3A gene subfamily in the mouse liver. | 1.15e-07 | 3 | 170 | 3 | 10775455 | |
| Pubmed | 1.15e-07 | 3 | 170 | 3 | 19226368 | ||
| Pubmed | 1.15e-07 | 3 | 170 | 3 | 19188337 | ||
| Pubmed | 1.15e-07 | 3 | 170 | 3 | 37258238 | ||
| Pubmed | 1.15e-07 | 3 | 170 | 3 | 28567424 | ||
| Pubmed | 1.15e-07 | 3 | 170 | 3 | 25005602 | ||
| Pubmed | 1.15e-07 | 3 | 170 | 3 | 11284050 | ||
| Pubmed | 1.15e-07 | 3 | 170 | 3 | 14733933 | ||
| Pubmed | 1.15e-07 | 3 | 170 | 3 | 21081028 | ||
| Pubmed | 1.15e-07 | 3 | 170 | 3 | 9143324 | ||
| Pubmed | 1.15e-07 | 3 | 170 | 3 | 22291988 | ||
| Pubmed | 1.15e-07 | 3 | 170 | 3 | 15548719 | ||
| Pubmed | CYP3A-mediated generation of aldehyde and hydrazine in atazanavir metabolism. | 1.15e-07 | 3 | 170 | 3 | 21148252 | |
| Pubmed | 1.15e-07 | 3 | 170 | 3 | 23370405 | ||
| Pubmed | Selective inactivation of mouse liver cytochrome P-450IIIA by cannabidiol. | 1.15e-07 | 3 | 170 | 3 | 2402224 | |
| Pubmed | 1.15e-07 | 3 | 170 | 3 | 7932176 | ||
| Pubmed | Metabolomics reveals the formation of aldehydes and iminium in gefitinib metabolism. | 1.15e-07 | 3 | 170 | 3 | 26212543 | |
| Pubmed | IQSEC3 MIA3 NCKAP1 PRR36 ABLIM3 SLC1A3 SPTBN4 NEFH FRY NF1 SBF1 SYNE2 MIOS PRKAR1A MACF1 HERC2 TOP3B ARHGAP21 DYNC1H1 | 2.89e-07 | 963 | 170 | 19 | 28671696 | |
| Pubmed | 4.57e-07 | 4 | 170 | 3 | 21088200 | ||
| Pubmed | 4.57e-07 | 4 | 170 | 3 | 36050438 | ||
| Pubmed | A novel form of mouse cytochrome P450 3A (Cyp3a-16). Its cDNA cloning and expression in fetal liver. | 4.57e-07 | 4 | 170 | 3 | 7813478 | |
| Pubmed | Knockout of cytochrome P450 3A yields new mouse models for understanding xenobiotic metabolism. | 4.57e-07 | 4 | 170 | 3 | 17975676 | |
| Pubmed | Bmal1 regulates circadian expression of cytochrome P450 3a11 and drug metabolism in mice. | 4.57e-07 | 4 | 170 | 3 | 31633069 | |
| Pubmed | Cyp2c70 is responsible for the species difference in bile acid metabolism between mice and humans. | 4.57e-07 | 4 | 170 | 3 | 27638959 | |
| Pubmed | Humanized xenobiotic response in mice expressing nuclear receptor SXR. | 4.57e-07 | 4 | 170 | 3 | 10935643 | |
| Pubmed | Knockout of mouse Cyp3a gene enhances synthesis of cholesterol and bile acid in the liver. | 4.57e-07 | 4 | 170 | 3 | 23709690 | |
| Pubmed | Thalidomide-induced limb abnormalities in a humanized CYP3A mouse model. | 4.57e-07 | 4 | 170 | 3 | 26903378 | |
| Pubmed | 4.57e-07 | 4 | 170 | 3 | 32130917 | ||
| Pubmed | 4.57e-07 | 4 | 170 | 3 | 17936928 | ||
| Pubmed | Genomic characterization and regulation of CYP3a13: role of xenobiotics and nuclear receptors. | 4.57e-07 | 4 | 170 | 3 | 12958193 | |
| Pubmed | 4.57e-07 | 4 | 170 | 3 | 10230766 | ||
| Pubmed | 4.57e-07 | 4 | 170 | 3 | 25319358 | ||
| Pubmed | The transcription factor E4bp4 regulates the expression and activity of Cyp3a11 in mice. | 4.57e-07 | 4 | 170 | 3 | 30796914 | |
| Pubmed | Mouse aortic muscle cells respond to oxygen following cytochrome P450 3A13 gene transfer. | 4.57e-07 | 4 | 170 | 3 | 23656416 | |
| Pubmed | 4.57e-07 | 4 | 170 | 3 | 7803471 | ||
| Pubmed | 4.57e-07 | 4 | 170 | 3 | 14509827 | ||
| Pubmed | 4.57e-07 | 4 | 170 | 3 | 23125282 | ||
| Pubmed | Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex. | 1.01e-06 | 37 | 170 | 5 | 27565344 | |
| Pubmed | EXOSC10 MIA3 NDUFAF2 SYNM WFS1 DNAJC30 ANKRD26 DNAJC27 PFAS PLD3 PFKP NDUFS8 KIAA0753 TUBGCP6 URB1 SBF1 SYNE2 ASCC2 PRKAR1A EIF5B MACF1 HERC2 TOP3B | 1.08e-06 | 1487 | 170 | 23 | 33957083 | |
| Pubmed | Sterol 27-hydroxylase gene dosage and the antiatherosclerotic effect of Rifampicin in mice. | 1.14e-06 | 5 | 170 | 3 | 29191818 | |
| Pubmed | Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene. | 1.14e-06 | 5 | 170 | 3 | 11266076 | |
| Pubmed | 1.14e-06 | 5 | 170 | 3 | 19920203 | ||
| Pubmed | Hepatic and hippocampal cytochrome P450 enzyme overexpression during spontaneous recurrent seizures. | 1.14e-06 | 5 | 170 | 3 | 29125184 | |
| Pubmed | 1.14e-06 | 5 | 170 | 3 | 23090875 | ||
| Pubmed | 1.14e-06 | 5 | 170 | 3 | 8006463 | ||
| Pubmed | 1.14e-06 | 5 | 170 | 3 | 29725048 | ||
| Pubmed | 1.14e-06 | 5 | 170 | 3 | 18156313 | ||
| Pubmed | 1.14e-06 | 5 | 170 | 3 | 32087611 | ||
| Pubmed | Characterization and expression pattern of the novel MIA homolog TANGO. | 1.14e-06 | 5 | 170 | 3 | 15183315 | |
| Pubmed | 1.25e-06 | 17 | 170 | 4 | 27197076 | ||
| Pubmed | Induction and genetic regulation of mouse hepatic cytochrome P450 by cannabidiol. | 2.27e-06 | 6 | 170 | 3 | 8043019 | |
| Pubmed | 2.27e-06 | 6 | 170 | 3 | 26265742 | ||
| Pubmed | 2.27e-06 | 6 | 170 | 3 | 21193583 | ||
| Pubmed | 2.27e-06 | 6 | 170 | 3 | 20926756 | ||
| Pubmed | 2.27e-06 | 6 | 170 | 3 | 21351274 | ||
| Pubmed | Opposing regulation of cytochrome P450 expression by CAR and PXR in hypothyroid mice. | 2.27e-06 | 6 | 170 | 3 | 22503787 | |
| Pubmed | 2.27e-06 | 6 | 170 | 3 | 14642533 | ||
| Pubmed | 2.27e-06 | 6 | 170 | 3 | 15930522 | ||
| Pubmed | KRT16 WDR4 EML6 ANKRD26 CTAGE6 PFKP PLA2G4D RYR2 SPTBN4 RIMKLB CLCN5 LMO7 SYNE2 CTAGE8 EIF5B CTAGE15 MACF1 CTAGE4 TOP3B ARHGAP21 DYNC1I1 BBOF1 | 2.36e-06 | 1442 | 170 | 22 | 35575683 | |
| Pubmed | The human cytochrome P450 3A locus. Gene evolution by capture of downstream exons. | 3.96e-06 | 7 | 170 | 3 | 11137287 | |
| Pubmed | 3.96e-06 | 7 | 170 | 3 | 27137100 | ||
| Pubmed | Joint effects of inflammation and androgen metabolism on prostate cancer severity. | 3.96e-06 | 7 | 170 | 3 | 18566991 | |
| Pubmed | Effects of infection of MRSA on the expression and activity of renal cytochrome P450s in mice. | 3.96e-06 | 7 | 170 | 3 | 30944282 | |
| Pubmed | 3.96e-06 | 7 | 170 | 3 | 27514509 | ||
| Pubmed | A novel transmembrane MSP-containing protein that plays a role in right ventricle development. | 3.96e-06 | 7 | 170 | 3 | 15533722 | |
| Pubmed | WDR4 SYNM LONRF1 RFX5 MSTO1 SPTBN4 FRY LMO7 PRKAR1A LRP4 MACF1 ASTN1 EXOC1 PAX6 HERC2 MERTK ARHGAP21 SNTA1 DYNC1H1 DYNC1I1 | 5.26e-06 | 1285 | 170 | 20 | 35914814 | |
| Pubmed | Identification and characterization of human FNBP3 gene in silico. | 6.31e-06 | 8 | 170 | 3 | 12964049 | |
| Pubmed | Drug metabolizing enzyme induction pathways in experimental non-alcoholic steatohepatitis. | 6.31e-06 | 8 | 170 | 3 | 18488193 | |
| Pubmed | 6.31e-06 | 8 | 170 | 3 | 18794335 | ||
| Pubmed | 6.31e-06 | 8 | 170 | 3 | 30910785 | ||
| Pubmed | 9.43e-06 | 9 | 170 | 3 | 3917435 | ||
| Pubmed | 9.43e-06 | 9 | 170 | 3 | 7678494 | ||
| Pubmed | 9.43e-06 | 9 | 170 | 3 | 16102745 | ||
| Pubmed | NCKAP1 WFS1 ABLIM3 SLC1A3 NEFH NF1 SBF1 MACF1 HERC2 ARHGAP21 SNTA1 | 9.66e-06 | 430 | 170 | 11 | 32581705 | |
| Pubmed | 1.27e-05 | 104 | 170 | 6 | 9205841 | ||
| Pubmed | 1.34e-05 | 10 | 170 | 3 | 26165599 | ||
| Pubmed | 1.65e-05 | 163 | 170 | 7 | 16512683 | ||
| Pubmed | Role of the Drug-Metabolizing Enzyme CYP during Mouse Liver Development. | 1.84e-05 | 11 | 170 | 3 | 27904043 | |
| Pubmed | EXOSC10 NCKAP1 PFAS PFKP URB1 NF1 SBF1 PHF3 SYNE2 EIF5B MACF1 HERC2 DYNC1H1 | 2.16e-05 | 653 | 170 | 13 | 22586326 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 27225724 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 29741614 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 28704257 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 15900284 | ||
| Pubmed | Genetic association in CYP3A4 and CYP3A5 genes elevate the risk of prostate cancer. | 2.38e-05 | 2 | 170 | 2 | 36688864 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 38237647 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 20715157 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 15900215 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 31309254 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 19343327 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 19907160 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 27841150 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 23583712 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 33512723 | ||
| Interaction | CTAGE1 interactions | 8.70e-09 | 10 | 166 | 5 | int:CTAGE1 | |
| Interaction | SNAPIN interactions | 1.14e-05 | 169 | 166 | 9 | int:SNAPIN | |
| Cytoband | 7q21.1 | 2.76e-06 | 8 | 170 | 3 | 7q21.1 | |
| Cytoband | 7q35 | 5.34e-05 | 55 | 170 | 4 | 7q35 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q35 | 1.09e-04 | 66 | 170 | 4 | chr7q35 | |
| GeneFamily | CTAGE family | 4.31e-08 | 15 | 126 | 5 | 907 | |
| GeneFamily | Cytochrome P450 family 3 | 1.80e-05 | 8 | 126 | 3 | 1002 | |
| GeneFamily | WD repeat domain containing | 9.25e-05 | 262 | 126 | 9 | 362 | |
| GeneFamily | Regulators of G-protein signaling | 4.01e-04 | 21 | 126 | 3 | 720 | |
| GeneFamily | Intermediate filaments Type IV | 7.10e-04 | 6 | 126 | 2 | 611 | |
| GeneFamily | EF-hand domain containing|Spectrins | 9.89e-04 | 7 | 126 | 2 | 1113 | |
| GeneFamily | Exocyst complex | 1.68e-03 | 9 | 126 | 2 | 1055 | |
| GeneFamily | Paired boxes | 1.68e-03 | 9 | 126 | 2 | 675 | |
| GeneFamily | Laminin subunits | 3.04e-03 | 12 | 126 | 2 | 626 | |
| GeneFamily | Dyneins, cytoplasmic | 3.57e-03 | 13 | 126 | 2 | 538 | |
| GeneFamily | Low density lipoprotein receptors | 3.57e-03 | 13 | 126 | 2 | 634 | |
| GeneFamily | PDZ domain containing | 4.25e-03 | 152 | 126 | 5 | 1220 | |
| GeneFamily | Dyneins, axonemal | 6.12e-03 | 17 | 126 | 2 | 536 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-07 | 155 | 170 | 8 | 51f6447945389649d99dcf7603b396195c631ead | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic-Mast_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-07 | 155 | 170 | 8 | 23dc71cab28094ca0ac4d2baf4e24871ed107781 | |
| ToppCell | facs-Brain_Myeloid-Striatum|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.43e-06 | 177 | 170 | 7 | efb1990fd1d216f64261e81017299783afb24a1e | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.28e-06 | 181 | 170 | 7 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.00e-06 | 184 | 170 | 7 | cb15d6bae52c5ec251c2235859dc7e65f630ae23 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.00e-06 | 184 | 170 | 7 | bde4eaabd3e9bdaed23867d23a919b9d84b52d4b | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 8.33e-06 | 189 | 170 | 7 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 8.63e-06 | 190 | 170 | 7 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.63e-06 | 190 | 170 | 7 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.02e-06 | 126 | 170 | 6 | 4eeea015efe17e0aae5bd76b71fa70b5149dfada | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 1.06e-05 | 196 | 170 | 7 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 1.06e-05 | 196 | 170 | 7 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD4+_T_activated|Control / Disease, condition lineage and cell class | 1.13e-05 | 198 | 170 | 7 | ee71543559836fd59adc0da877b2ca538cba60cb | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-05 | 132 | 170 | 6 | 4152529611eeacf0c547e2a134d5b98c45426b13 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Stem_cells-stem_cells_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 2.62e-05 | 152 | 170 | 6 | 375c9ef88c7703a002e868645a722c35e046ef1e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.14e-05 | 157 | 170 | 6 | bfec34182f052cf1c0d847ba53ea335d4d1190de | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.87e-05 | 163 | 170 | 6 | 1eec7f5e5fed05fa21d3f81db588f10605f08ea7 | |
| ToppCell | control-Epithelial-Ionocyte|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.15e-05 | 165 | 170 | 6 | 5cfba9a46bd8ceeca74a6493057b4d38af6b06fe | |
| ToppCell | NS-control-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.29e-05 | 166 | 170 | 6 | 6d9fb239f69ba519844f593c00d515e1aac4ff50 | |
| ToppCell | control-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.58e-05 | 168 | 170 | 6 | 327b02f19f4a8607c033203824fdc60a1254331f | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-mesothelial_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.74e-05 | 169 | 170 | 6 | 0cece9b2bb1f58e465c20ec8735a4fc3c1021f03 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.74e-05 | 169 | 170 | 6 | 6937c46b119d4ce382fc8c2fa5925ede5ae89c81 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.90e-05 | 170 | 170 | 6 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-2|ILC / Donor, Lineage, Cell class and subclass (all cells) | 5.23e-05 | 172 | 170 | 6 | 4977e1f4deae781750e27a8054deccd336cfb74a | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 5.23e-05 | 172 | 170 | 6 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.23e-05 | 172 | 170 | 6 | 073a503dc922e3e3ac3528e249b0f8b74402110b | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.57e-05 | 174 | 170 | 6 | b7f5492ce8098f7eb0aef30ee558d00738d59d0e | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.57e-05 | 174 | 170 | 6 | 71730503be3d9c839c4c9e950145e2101d682a1c | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.57e-05 | 174 | 170 | 6 | ee8ac51fa0b426ad7b7453371bb79c8bf8c1d358 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.57e-05 | 174 | 170 | 6 | cafe4d6b5f08d8888e9db6e196c66df991c03e7b | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.13e-05 | 177 | 170 | 6 | 26bad614560609d318bfc9c235a698bca4e1c22c | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.52e-05 | 179 | 170 | 6 | 021d782134126c6f7dce6b6ea50cc54bdaa39987 | |
| ToppCell | droplet-Fat-Gat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.52e-05 | 179 | 170 | 6 | 08cf9986804a6417a9afb19b50c69a3554f71ec6 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.72e-05 | 180 | 170 | 6 | 8af8b4af2dc72223ac71fc027e0d4280c5dd81f8 | |
| ToppCell | MatrixFB-Fibroblast-A|MatrixFB / shred on cell class and cell subclass (v4) | 6.72e-05 | 180 | 170 | 6 | adc64ad6033af705dd7b9163a83e20ef5c59f6eb | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.15e-05 | 182 | 170 | 6 | fd786c88826ad3d5cc5c3d80f8e392d6be1b5267 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 7.15e-05 | 182 | 170 | 6 | 04ccfa951eaa31fed6d140edb6c702d49363c5fa | |
| ToppCell | COPD-Epithelial-Basal|COPD / Disease state, Lineage and Cell class | 7.37e-05 | 183 | 170 | 6 | 0f760e393edc91009bf6c7e02eeac039a1dfb4ed | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.37e-05 | 183 | 170 | 6 | ebe369dc80c4fbf8f4dbe947147f8c47507ffb60 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.59e-05 | 184 | 170 | 6 | a60802e11dcc5f932811260b08a95a32f60f6b19 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.59e-05 | 184 | 170 | 6 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.59e-05 | 184 | 170 | 6 | 39c230d32e4259bc784e0edfd9e2884c96898564 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.59e-05 | 184 | 170 | 6 | 2a2fb691cc9414ef5b06c26239d2da03d6d7e5c2 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.59e-05 | 184 | 170 | 6 | 453295362888c9a59d0e73c7a5b15914c50ff591 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.82e-05 | 185 | 170 | 6 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 7.82e-05 | 185 | 170 | 6 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Endothelial-lymphatic_endothelial|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.06e-05 | 186 | 170 | 6 | eeacf59a9e6bf1c9fd59b6b13d35e8abae228cf0 | |
| ToppCell | moderate-Epithelial-Ionocyte|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.30e-05 | 187 | 170 | 6 | 3e3fe2d5712a0ac477cddefe56705d4b8d8f7eac | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.54e-05 | 188 | 170 | 6 | 9db778c1d9e622a68337212296e3a1ed8f771fa5 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 8.54e-05 | 188 | 170 | 6 | f5102e8d95506c25c675094b86162a6a50087b64 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.80e-05 | 189 | 170 | 6 | 7fbe855bfdb47d35e040b04a80fe4b729a3764e8 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.80e-05 | 189 | 170 | 6 | a959c9d6a0866582688a4204d625c1e5a123e93d | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.80e-05 | 189 | 170 | 6 | 09dd2b3d89416192e84abe302a6237b8f3fdcb6e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.80e-05 | 189 | 170 | 6 | 06b35abecd29f902cf251fcc1f6ad33db7ab08a2 | |
| ToppCell | moderate-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.80e-05 | 189 | 170 | 6 | 6011b747e27d61d222380a7bffdd921a68e9b657 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.06e-05 | 190 | 170 | 6 | 5c64b727669b23d2a23c8ad1d5d6caab7af37d56 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 9.32e-05 | 191 | 170 | 6 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.32e-05 | 191 | 170 | 6 | df8cdbc26443e55a203cbafa21b0952a2a55b9bf | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.32e-05 | 191 | 170 | 6 | 361b123c8289015206d5e706ab2c615d9a724179 | |
| ToppCell | COPD-Epithelial-Club|COPD / Disease state, Lineage and Cell class | 9.32e-05 | 191 | 170 | 6 | c909cf5fa0e6519aa93a47d2c3fcd2ae2163cd8d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.32e-05 | 191 | 170 | 6 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.32e-05 | 191 | 170 | 6 | 06760c3bb40e4f66879a5f5e09c9abfce4ebbba3 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-NK|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.59e-05 | 192 | 170 | 6 | 930319cbd82b9e54864147ffcdc8bd0ea7b937be | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 9.59e-05 | 192 | 170 | 6 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-NK-NK|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.59e-05 | 192 | 170 | 6 | c7bcebcb88a25b2c97d798120efa9d5958e7f798 | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.59e-05 | 192 | 170 | 6 | ee9a23a4f00424a50bd7907cf3b12dc50027877e | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.59e-05 | 192 | 170 | 6 | d6f656be2698bd215717d35f4e7ab727c08c61e0 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.87e-05 | 193 | 170 | 6 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.87e-05 | 193 | 170 | 6 | bd0027fa97de41ae22ff64a61c8e217496f122ca | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.02e-04 | 194 | 170 | 6 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-NK-NK-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.02e-04 | 194 | 170 | 6 | 3211d89440a6f4a9b3d4cfb755890816944242ec | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 194 | 170 | 6 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.04e-04 | 195 | 170 | 6 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.04e-04 | 195 | 170 | 6 | 22a481927147ec4ae9d59e6af7c87df0e9cb51e4 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|lung / Disease (COVID-19 only), tissue and cell type | 1.04e-04 | 195 | 170 | 6 | 148fff8c3c9ba45ec36e98dff1be57e3f8294506 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.04e-04 | 195 | 170 | 6 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 195 | 170 | 6 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.07e-04 | 196 | 170 | 6 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Ionocyte_n_Brush|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.07e-04 | 196 | 170 | 6 | ef650ff106a76c1e926e13c7f002fbc452cc48ae | |
| ToppCell | COVID-19-Myeloid-Transitioning_MDM|COVID-19 / group, cell type (main and fine annotations) | 1.07e-04 | 196 | 170 | 6 | 4929cfed1f150c1fde4d79cb49895c2ea467a18f | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.07e-04 | 196 | 170 | 6 | eb68f7954e7c2f86d05e740e95b6e74805a6053f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.07e-04 | 196 | 170 | 6 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_Erythro-Mega|bone_marrow / Manually curated celltypes from each tissue | 1.07e-04 | 196 | 170 | 6 | 707eecbb2b14051fd843afa66035014ec59e6bd5 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.07e-04 | 196 | 170 | 6 | 72b6a68ee760599ea86cd2d712bfd17b7b4ee417 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_Erythro-Mega-Erythrocytic_early|bone_marrow / Manually curated celltypes from each tissue | 1.07e-04 | 196 | 170 | 6 | 507254c4c00e535fe01851431b5b74a5f15d9592 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 123 | 170 | 5 | a45d6907c041ad3f3218cd46dccfc25d4bd961cb | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-04 | 197 | 170 | 6 | 3a0e97bfebe82f9687d518baaad7f20d0ffea8a1 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.10e-04 | 197 | 170 | 6 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.14e-04 | 198 | 170 | 6 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.14e-04 | 198 | 170 | 6 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.14e-04 | 198 | 170 | 6 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.14e-04 | 198 | 170 | 6 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Parenchyma_COVID-19-Immune-TX-MoAM-4|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.14e-04 | 198 | 170 | 6 | a7eed9eeb728a8796e2780090cc244856efd8c65 | |
| ToppCell | mild-CD4+_Tcm|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.17e-04 | 199 | 170 | 6 | 06c8a0e39f7a33736548f04a5e2263334c8541cf | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 125 | 170 | 5 | 35042ed43045dddc341b76cc5f9fe31b5ba0abb8 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.20e-04 | 200 | 170 | 6 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.20e-04 | 200 | 170 | 6 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | Macroglial-Astrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.20e-04 | 200 | 170 | 6 | 941536b7c32f1e63c70535233b2ccce0cd7bf96e | |
| ToppCell | Biopsy_Other_PF-Epithelial-KRT5-/KRT17+|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.20e-04 | 200 | 170 | 6 | 077e6b9340686de9d0f11b035a8954e1f6a1b790 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.20e-04 | 200 | 170 | 6 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 6.80e-05 | 49 | 95 | 5 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Drug | AC1L1J6H | CYP3A4 CYP3A5 CYP3A43 GPT IFI44 USHBP1 ABCC8 LRP4 LRP6 HTR3B LRP2BP | 1.52e-06 | 236 | 168 | 11 | CID000004889 |
| Drug | (+/-)-thalidomide; Down 200; 100uM; MCF7; HG-U133A | 1.45e-05 | 194 | 168 | 9 | 606_DN | |
| Drug | 15(S)-15-methyl Prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A | 1.45e-05 | 194 | 168 | 9 | 7494_UP | |
| Drug | Hydrastinine hydrochloride [4884-68-8]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 1.51e-05 | 195 | 168 | 9 | 2283_DN | |
| Drug | Ticlopidine hydrochloride [53885-35-1]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 1.51e-05 | 195 | 168 | 9 | 4155_DN | |
| Drug | acetylmethadol | 1.55e-05 | 21 | 168 | 4 | CID000010517 | |
| Drug | Kaempferol [520-18-3]; Up 200; 14uM; MCF7; HT_HG-U133A | 1.57e-05 | 196 | 168 | 9 | 3579_UP | |
| Drug | Proguanil hydrochloride [637-32-1]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 1.64e-05 | 197 | 168 | 9 | 5506_UP | |
| Drug | N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; MCF7; HT_HG-U133A | 1.64e-05 | 197 | 168 | 9 | 3930_DN | |
| Drug | Tenoxicam [59804-37-4]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.64e-05 | 197 | 168 | 9 | 2860_UP | |
| Drug | Trimeprazine tartrate [4330-99-8]; Down 200; 5.4uM; MCF7; HT_HG-U133A | 1.70e-05 | 198 | 168 | 9 | 7235_DN | |
| Drug | (S)-(-)-Atenolol [93379-54-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 1.70e-05 | 198 | 168 | 9 | 6444_DN | |
| Drug | polybrominated biphenyl | 1.77e-05 | 44 | 168 | 5 | CID000042948 | |
| Drug | PF-00562151-00 [351320-12-2]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.77e-05 | 199 | 168 | 9 | 5954_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.77e-05 | 199 | 168 | 9 | 3872_UP | |
| Drug | precocene I | 2.15e-05 | 8 | 168 | 3 | CID000028619 | |
| Drug | plakin | 3.25e-05 | 82 | 168 | 6 | CID000018752 | |
| Drug | simvastatin | CYP3A4 CYP3A5 CYP3A43 GPT IFI44 USHBP1 ABCC8 LRP4 LRP6 FGF4 HTR3B LRP2BP | 3.46e-05 | 390 | 168 | 12 | CID000054454 |
| Drug | NDMA | 4.05e-05 | 52 | 168 | 5 | CID000008749 | |
| Drug | 4-hydroxymidazolam | 5.41e-05 | 2 | 168 | 2 | ctd:C042940 | |
| Drug | dehydrorotenone | 5.41e-05 | 2 | 168 | 2 | CID000099190 | |
| Drug | norverapamil | 5.41e-05 | 2 | 168 | 2 | ctd:C016904 | |
| Drug | 5,6-dihydro-2H-pyran-2-one | 5.41e-05 | 2 | 168 | 2 | CID000520660 | |
| Drug | NSC254180 | 5.41e-05 | 2 | 168 | 2 | CID000099639 | |
| Drug | notopterol | 5.41e-05 | 2 | 168 | 2 | CID005320227 | |
| Drug | N-acetyl-S--(1,2,3,4,4-pentachlorobutadienyl)cysteine sulfoxide | 5.41e-05 | 2 | 168 | 2 | ctd:C114289 | |
| Drug | acetylalanylalanine | 5.41e-05 | 2 | 168 | 2 | CID000088328 | |
| Drug | 3-hydroxyxanthine | 5.41e-05 | 2 | 168 | 2 | CID000083520 | |
| Drug | 6 beta-hydroxytestosterone | 5.41e-05 | 2 | 168 | 2 | ctd:C025591 | |
| Drug | 2-acetamidonaphthalene | 5.41e-05 | 2 | 168 | 2 | CID000011394 | |
| Drug | CQA 206-291 | 5.41e-05 | 2 | 168 | 2 | ctd:C059483 | |
| Drug | fructus schizandrae, radix ginseng, radix ophiopogonis drug combination | 5.41e-05 | 2 | 168 | 2 | ctd:C009252 | |
| Drug | AC1L1IZE | 5.44e-05 | 131 | 168 | 7 | CID000004799 | |
| Drug | sphondin | 6.23e-05 | 11 | 168 | 3 | CID000108104 | |
| Drug | AC1Q6DJO | 6.62e-05 | 93 | 168 | 6 | CID000000630 | |
| Drug | AC1L1CIR | 6.88e-05 | 58 | 168 | 5 | CID000001918 | |
| Drug | nitroxyl | 7.18e-05 | 185 | 168 | 8 | CID000000945 | |
| Drug | 5-hydroxydiclofenac | 8.27e-05 | 12 | 168 | 3 | CID003052566 | |
| Drug | Furosemide [54-31-9]; Down 200; 12uM; MCF7; HT_HG-U133A | 9.65e-05 | 193 | 168 | 8 | 3197_DN | |
| Drug | vanadyl | NPPC PDE1C IFI44 LAMB2 ZHX2 DNAH1 DNAH17 PRKAR1A LRP6 DYNC1H1 | 9.89e-05 | 307 | 168 | 10 | CID000061671 |
| Drug | Tetrahydroxy-1,4-quinone monohydrate [319-89-1]; Down 200; 21uM; MCF7; HT_HG-U133A | 1.00e-04 | 194 | 168 | 8 | 4159_DN | |
| Drug | Aconitine [302-27-2]; Up 200; 6.2uM; MCF7; HT_HG-U133A | 1.00e-04 | 194 | 168 | 8 | 2776_UP | |
| Drug | Pentamidine isethionate [140-64-7]; Up 200; 6.8uM; PC3; HT_HG-U133A | 1.00e-04 | 194 | 168 | 8 | 4573_UP | |
| Drug | 15d-PGJ2; Up 200; 10uM; PC3; HG-U133A | 1.00e-04 | 194 | 168 | 8 | 446_UP | |
| Drug | Dihydroergotoxine mesylate [8067-24-1]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 1.00e-04 | 194 | 168 | 8 | 2793_DN | |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 1.04e-04 | 195 | 168 | 8 | 2308_DN | |
| Drug | Pargyline hydrochloride [306-07-0]; Down 200; 20.4uM; PC3; HT_HG-U133A | 1.04e-04 | 195 | 168 | 8 | 2102_DN | |
| Drug | Chlorpromazine hydrochloride [69-09-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.04e-04 | 195 | 168 | 8 | 1700_DN | |
| Drug | Estradiol-17 beta [50-28-2]; Up 200; 14.6uM; PC3; HT_HG-U133A | 1.04e-04 | 195 | 168 | 8 | 6718_UP | |
| Drug | (R)-Propranolol hydrochloride [13071-11-9]; Down 200; 13.6uM; PC3; HT_HG-U133A | 1.04e-04 | 195 | 168 | 8 | 5814_DN | |
| Drug | THDCA | 1.07e-04 | 13 | 168 | 3 | CID000119046 | |
| Drug | NSC-13158 | 1.07e-04 | 13 | 168 | 3 | CID000079470 | |
| Drug | 2-chloro-1,1-difluoroethene | 1.07e-04 | 13 | 168 | 3 | CID000009664 | |
| Drug | Meclofenamic acid sodium salt monohydrate [6385-02-0]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.07e-04 | 196 | 168 | 8 | 2291_DN | |
| Drug | Ethambutol dihydrochloride [1070-11-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 1.07e-04 | 196 | 168 | 8 | 4120_DN | |
| Drug | Amyleine hydrochloride [532-59-2]; Down 200; 14.8uM; PC3; HT_HG-U133A | 1.11e-04 | 197 | 168 | 8 | 4089_DN | |
| Drug | Alclometasone dipropionate [667634-13-2]; Down 200; 7.6uM; PC3; HT_HG-U133A | 1.11e-04 | 197 | 168 | 8 | 5752_DN | |
| Drug | (-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 1.11e-04 | 197 | 168 | 8 | 3531_UP | |
| Drug | Pentolinium bitartrate [52-62-0]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 1.11e-04 | 197 | 168 | 8 | 2305_UP | |
| Drug | Amikacin hydrate [37517-28-5]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 1.11e-04 | 197 | 168 | 8 | 3233_UP | |
| Drug | staurosporine; Up 200; 1uM; MCF7; HG-U133A | 1.11e-04 | 197 | 168 | 8 | 312_UP | |
| Drug | Diprophylline [479-18-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 1.11e-04 | 197 | 168 | 8 | 5482_DN | |
| Drug | Alprostadil [745-65-3]; Down 200; 11.2uM; PC3; HT_HG-U133A | 1.15e-04 | 198 | 168 | 8 | 4099_DN | |
| Drug | Sulfachloropyridazine [80-32-0]; Down 200; 14uM; MCF7; HT_HG-U133A | 1.15e-04 | 198 | 168 | 8 | 3944_DN | |
| Drug | Trimipramine maleate salt [521-78-8]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 1.15e-04 | 198 | 168 | 8 | 3342_UP | |
| Drug | Acacetin [480-44-4]; Up 200; 14uM; MCF7; HT_HG-U133A | 1.15e-04 | 198 | 168 | 8 | 6044_UP | |
| Drug | Lobelanidine hydrochloride [6112-86-3]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 1.15e-04 | 198 | 168 | 8 | 5500_UP | |
| Drug | Condelphine [7633-69-4]; Up 200; 8.8uM; PC3; HT_HG-U133A | 1.19e-04 | 199 | 168 | 8 | 6357_UP | |
| Drug | Fluvastatin sodium salt [93957-55-2]; Up 200; 9.2uM; HL60; HT_HG-U133A | 1.19e-04 | 199 | 168 | 8 | 3032_UP | |
| Drug | Ganciclovir [82410-32-0]; Up 200; 15.6uM; HL60; HT_HG-U133A | 1.23e-04 | 200 | 168 | 8 | 3030_UP | |
| Drug | Xylazine [7361-61-7]; Up 200; 18.2uM; MCF7; HT_HG-U133A | 1.23e-04 | 200 | 168 | 8 | 2788_UP | |
| Drug | 9-hydroxyellipticine | 1.35e-04 | 14 | 168 | 3 | CID000091643 | |
| Drug | tamarixetin | 1.35e-04 | 14 | 168 | 3 | CID005281699 | |
| Drug | g due | 1.40e-04 | 36 | 168 | 4 | CID000062612 | |
| Drug | erythralosamine | 1.62e-04 | 3 | 168 | 2 | CID000352196 | |
| Drug | Rifabutin | 1.62e-04 | 3 | 168 | 2 | ctd:D017828 | |
| Drug | 3-methoxymorphinan | 1.62e-04 | 3 | 168 | 2 | ctd:C028657 | |
| Drug | dechloroethylcyclophosphamide | 1.62e-04 | 3 | 168 | 2 | ctd:C064445 | |
| Drug | 6 beta-hydroxydexamethasone | 1.62e-04 | 3 | 168 | 2 | CID000063050 | |
| Drug | territrem C | 1.62e-04 | 3 | 168 | 2 | CID000160306 | |
| Drug | N-hydroxy-L-tyrosine | 1.62e-04 | 3 | 168 | 2 | CID000174052 | |
| Drug | tetrabenzonaphthalene | 1.62e-04 | 3 | 168 | 2 | CID000067449 | |
| Drug | 4,4'-dihydroxyantipyrine | 1.62e-04 | 3 | 168 | 2 | CID000126307 | |
| Drug | megazol | 1.62e-04 | 3 | 168 | 2 | CID000029698 | |
| Drug | 1-hydroxymethylmidazolam | 1.62e-04 | 3 | 168 | 2 | ctd:C040081 | |
| Drug | fomocaine | 1.62e-04 | 3 | 168 | 2 | CID000071693 | |
| Drug | phenanthrene-4,5-dicarboxylic acid | 1.62e-04 | 3 | 168 | 2 | CID000095075 | |
| Drug | 3-sulfanylhexyl acetate | 1.62e-04 | 3 | 168 | 2 | CID000518810 | |
| Drug | N-acetyl-S-pentachloro-1,3-butadienylcysteine | 1.62e-04 | 3 | 168 | 2 | ctd:C049739 | |
| Drug | C15503 | 1.62e-04 | 3 | 168 | 2 | CID005461147 | |
| Drug | SCE-129 | 1.63e-04 | 156 | 168 | 7 | CID000002648 | |
| Drug | PRODAN | 1.68e-04 | 15 | 168 | 3 | CID000028127 | |
| Drug | UROX | 1.68e-04 | 15 | 168 | 3 | CID000008799 | |
| Drug | AC1L1AFQ | 1.68e-04 | 15 | 168 | 3 | CID000000969 | |
| Drug | 2-(allylthio)pyrazine | 2.06e-04 | 16 | 168 | 3 | CID003025899 | |
| Drug | 2,2,2-trichloroethanol | 2.06e-04 | 73 | 168 | 5 | CID000008259 | |
| Drug | dipyrone | 2.12e-04 | 40 | 168 | 4 | CID000003110 | |
| Drug | senecionine | 2.20e-04 | 74 | 168 | 5 | ctd:C009237 | |
| Drug | PDEs | 2.24e-04 | 116 | 168 | 6 | CID003036959 | |
| Drug | Epi Lovastatin | CYP3A4 CYP3A5 CYP3A43 GPT TGFB3 NEFH USHBP1 LRP4 LRP6 LRP2BP | 2.32e-04 | 341 | 168 | 10 | CID000003962 |
| Disease | Malignant neoplasm of breast | GPC1 ADAMTS19 WWOX CYP3A4 DTX3 LAMA2 DYSF NR2F1 NLRP9 NF1 ABRAXAS1 ANKEF1 SYNE2 FGF4 MACF1 ZFYVE26 HERC2 ZNF646 | 1.93e-05 | 1074 | 158 | 18 | C0006142 |
| Disease | metabolonic lactone sulfate measurement | 1.37e-04 | 19 | 158 | 3 | EFO_0800659 | |
| Disease | tacrolimus measurement | 1.70e-04 | 4 | 158 | 2 | EFO_0008458 | |
| Disease | muscular dystrophy (implicated_via_orthology) | 1.87e-04 | 21 | 158 | 3 | DOID:9884 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 2.55e-04 | 163 | 158 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | unipolar depression, neuroticism measurement | 2.81e-04 | 24 | 158 | 3 | EFO_0003761, EFO_0007660 | |
| Disease | Congenital muscular dystrophy (disorder) | 4.21e-04 | 6 | 158 | 2 | C0699743 | |
| Disease | episodic ataxia type 6 (implicated_via_orthology) | 4.21e-04 | 6 | 158 | 2 | DOID:0050994 (implicated_via_orthology) | |
| Disease | X-12063 measurement | 5.14e-04 | 186 | 158 | 6 | EFO_0021283 | |
| Disease | Intellectual Disability | 7.14e-04 | 447 | 158 | 9 | C3714756 | |
| Disease | glucagon-like peptide-1 measurement, glucose tolerance test | 7.81e-04 | 8 | 158 | 2 | EFO_0004307, EFO_0008465 | |
| Disease | Profound Mental Retardation | 9.33e-04 | 139 | 158 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 9.33e-04 | 139 | 158 | 5 | C0025363 | |
| Disease | Mental deficiency | 9.33e-04 | 139 | 158 | 5 | C0917816 | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 9.45e-04 | 36 | 158 | 3 | DOID:11723 (implicated_via_orthology) | |
| Disease | Disorder of eye | 1.02e-03 | 212 | 158 | 6 | C0015397 | |
| Disease | squamous cell lung carcinoma, family history of lung cancer | 1.14e-03 | 85 | 158 | 4 | EFO_0000708, EFO_0006953 | |
| Disease | Odontome | 1.25e-03 | 10 | 158 | 2 | C0524730 | |
| Disease | arrhythmogenic right ventricular cardiomyopathy (is_implicated_in) | 1.25e-03 | 10 | 158 | 2 | DOID:0050431 (is_implicated_in) | |
| Disease | Tooth Abnormalities | 1.25e-03 | 10 | 158 | 2 | C0040427 | |
| Disease | testosterone measurement | MIA3 WWOX DCDC1 CYP3A4 MYO9B EML4 KIAA0753 SLC30A6 BMP6 URB1 NF1 SYNE2 MACF1 HHIPL1 ARHGAP21 ARAP1 | 1.40e-03 | 1275 | 158 | 16 | EFO_0004908 |
| Disease | nevus count, cutaneous melanoma | 1.47e-03 | 91 | 158 | 4 | EFO_0000389, EFO_0004632 | |
| Disease | methionine sulfone measurement | 1.82e-03 | 12 | 158 | 2 | EFO_0800072 | |
| Disease | actinic keratosis | 2.49e-03 | 14 | 158 | 2 | EFO_0002496 | |
| Disease | Schizophrenia | CYP3A4 CYP3A5 MYO9B LAMA2 SLC1A3 SLC1A6 RGS12 APOL4 PAX6 HTR3B TOP3B HCRTR1 | 2.94e-03 | 883 | 158 | 12 | C0036341 |
| Disease | alcohol dependence measurement | 3.22e-03 | 55 | 158 | 3 | EFO_0007835 | |
| Disease | forced expiratory volume | CERKL WWOX CYP3A4 EML4 DNAJC27 ZHX2 ABLIM3 RYR2 KIAA0753 BMP6 ASCC2 | 3.60e-03 | 789 | 158 | 11 | EFO_0004314 |
| Disease | muscular dystrophy (is_implicated_in) | 3.68e-03 | 17 | 158 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | cutaneous melanoma, hair color | 4.52e-03 | 62 | 158 | 3 | EFO_0000389, EFO_0003924 | |
| Disease | obsessive-compulsive disorder, autism spectrum disorder | 4.59e-03 | 19 | 158 | 2 | EFO_0003756, EFO_0004242 | |
| Disease | reasoning | 4.59e-03 | 19 | 158 | 2 | EFO_0004350 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AWLRLALSSREDELV | 181 | Q8N6Y0 | |
| LDDRWQFKRSRLLDT | 351 | Q6UWZ7 | |
| ERAWALDVAELHRAL | 211 | P24298 | |
| TISEFDRLALWKRNE | 661 | O94929 | |
| AAADETLRLWRCFEL | 461 | Q12834 | |
| WLAARTAERNLSDLR | 466 | Q8IX94 | |
| WLAARTAERNLSDLR | 466 | Q86UF2 | |
| WLAARTAERNLSDLR | 466 | P0CG41 | |
| WLAARTAERNLSDLR | 466 | A4FU28 | |
| WLAARTAERNLSDLR | 466 | A4D2H0 | |
| EAEWREALRALRAAA | 171 | Q9H7E9 | |
| EAEVELSARRLRAWG | 621 | Q8IZ83 | |
| DLLSRWTADRLDAVV | 126 | P22760 | |
| LTSDEAWKRFVRVAE | 56 | Q9BPW4 | |
| SAISLAEDEEWKRIR | 116 | P20815 | |
| QEAEWLVLLSRFDRL | 401 | O95264 | |
| ADERVLWLAQREAKA | 496 | Q8IWK6 | |
| LERATFVANDLDWLL | 56 | Q9H1I8 | |
| RALDWVASANLLDDI | 961 | C9J069 | |
| ALRLHDWSVEREAFL | 326 | Q9NU02 | |
| KVEWERELCSLRFSL | 781 | Q9UPS8 | |
| LLRDLRVDTKSRAAW | 71 | P23582 | |
| REALLARLEWFEGQA | 731 | Q9NVE4 | |
| ASLWEARLEVTELSR | 36 | Q8ND07 | |
| EGAERKSLEDLARWR | 436 | A6NI56 | |
| LDWAELSRDLRKTCE | 1271 | O14525 | |
| FDRRWDDTILSSALA | 236 | Q8NFJ5 | |
| ALTCDWAERILKRSF | 206 | P48382 | |
| ELAARLLFSAVEWAR | 221 | P10589 | |
| WSRCSKEDLERFLRS | 521 | Q8TE59 | |
| WQRVFAALSDSRLLL | 966 | Q6DT37 | |
| RVWSLERRLAAAEET | 131 | Q9BUH6 | |
| RKDAEAWFNERSATL | 271 | Q7Z3Y9 | |
| SIFAWEIRDRLLSEG | 96 | P26367 | |
| LGRWDLFREDLVRSA | 181 | Q8NBL1 | |
| ELDTRKAIRQAFDVW | 181 | Q9Y5R2 | |
| LRSQLEAIFLRDWDS | 456 | Q8IV08 | |
| RDLVLWALDESFLQR | 1466 | M0R2J8 | |
| SERLFSLELLVDWVR | 6 | Q9P2G4 | |
| ALWRRAITEAREEAK | 16 | Q12866 | |
| GRDAELTRRFWALAS | 51 | Q96JK4 | |
| LTRRFWALASRVDAA | 56 | Q96JK4 | |
| LSLAFRTRDSEAWLL | 896 | Q5IJ48 | |
| RTRDSEAWLLRAAAG | 901 | Q5IJ48 | |
| ADAIRRIRNSKDSWD | 206 | Q9NZQ0 | |
| ETLAEFWARLLERLF | 161 | P35052 | |
| AFLRRAWRSGEDADL | 206 | O95714 | |
| TELWENKRFLRAALS | 26 | Q8N0V5 | |
| AAAESERWELLLRRG | 41 | Q17RB8 | |
| LAARALRSFRWQSLE | 21 | Q9NVL1 | |
| LRSFRWQSLEAKLRD | 26 | Q9NVL1 | |
| DEWTRFARTLVEIRA | 616 | O14576 | |
| SAISIAEDEEWKRLR | 116 | P08684 | |
| KAWAFDLSLEALRRT | 231 | Q8IWD5 | |
| AELERRWESLVALSL | 41 | P08620 | |
| EALARDLTKLDLRRW | 521 | Q9BUK6 | |
| LSKDDWREFRTLVIE | 321 | Q14123 | |
| LFRKEWSGLLEELAR | 136 | Q01813 | |
| AELRVKFLQARDAWL | 241 | Q96MW5 | |
| RRDAETWFLSKTEEL | 301 | P08779 | |
| TELELFKAACRWLRL | 211 | Q9P2J3 | |
| EADLKRWEAIREASR | 666 | Q8WWI1 | |
| SRLGKLFWADSDLRR | 1111 | O75581 | |
| LFWADSDLRRIESSD | 1116 | O75581 | |
| LLQDARRARSWAEDE | 1586 | P55268 | |
| RSNEEAERLWLIAAD | 151 | Q9P2M1 | |
| DLWEAALTYEASKRR | 281 | Q96RT7 | |
| AWDLLREATDKIREA | 1786 | P24043 | |
| KWEDLRRVAVESAEA | 396 | A8MYU2 | |
| WATALARRVAAELQA | 371 | P03971 | |
| REWLEVLEDTKRALS | 271 | Q8IYI6 | |
| RDEEALRALAWLRGT | 226 | Q9UGQ3 | |
| RRLDELSAENRSLWE | 41 | Q9UPP2 | |
| SADSRVKLWDVRRAS | 206 | Q13216 | |
| SFARDEIIWLLRHAD | 376 | Q9Y2A7 | |
| LLEWLSEAEQTLRFR | 6781 | Q9UPN3 | |
| ERSALDVASEQRRLW | 721 | O95248 | |
| VTDRAARTLLWTELF | 51 | O00217 | |
| EWFRVRLDRLSEAAK | 291 | P12036 | |
| IFAWEIRDRLLADGV | 191 | P15863 | |
| TRLFSVCDERWADDL | 196 | O43613 | |
| LRWALDDVVAFRLNS | 241 | Q9H3Q3 | |
| WEDARRRALDVATFA | 176 | O60755 | |
| AEEEELKEARRALSW | 496 | A2A2Y4 | |
| LSDRAWRDILALSNL | 3566 | Q9P2D7 | |
| WDFLSKETPARLARL | 26 | Q8N9I9 | |
| QLLFAWRDKTARRED | 511 | Q01780 | |
| ILSALRRMLWAADDF | 406 | Q8TCB0 | |
| RRDSALTALDEETLW | 6 | Q9BXL6 | |
| SALSFAEDEEWKRIR | 116 | Q9HB55 | |
| LLRIRELEAWTTDFA | 4301 | Q9UFH2 | |
| TLIIAVDWFLDRLRT | 466 | P43003 | |
| DFNTIDWVREKSRDR | 86 | P51795 | |
| RDSDLFLLDTRVVWA | 286 | P22004 | |
| RDSCDVVLSERALRW | 56 | Q49MI3 | |
| TLIIAVDWFLDRLRT | 491 | P48664 | |
| LSRLLGDSTFEWVAR | 316 | Q92611 | |
| LLCEFSDRRLLDKWV | 256 | O60336 | |
| RLRETWALARDAALV | 556 | Q6ZW76 | |
| WALARDAALVLDQLR | 561 | Q6ZW76 | |
| TALLKSLSAERERWE | 3476 | Q14204 | |
| LESLDKWERLTVADA | 256 | P10644 | |
| RQIAWALRDLAVVDA | 66 | Q9NV70 | |
| RWFVLDAETRDLVSI | 656 | Q9HC35 | |
| DRSVRLWSLADHALI | 346 | Q6ZMW3 | |
| WGVRRRSLDSLDKCD | 2481 | Q5TBA9 | |
| LRWEDTRDTAAIFLI | 201 | Q96LL9 | |
| AASLRLRARWESALD | 941 | Q14147 | |
| DWLISRLERLEASSG | 556 | Q92736 | |
| QAEDWLLRLRALAEE | 771 | O75923 | |
| SVWRELALASQARLA | 386 | O15547 | |
| ESARREIALWFRADE | 141 | Q13232 | |
| ARNLRWADLLSEADP | 31 | Q86XP0 | |
| RLASRRSFWAELNVA | 96 | P00540 | |
| LDRVARAWFADLAEL | 266 | Q9GZU5 | |
| RELRDWGLSFDSNLL | 436 | Q96J94 | |
| RKLTVEDFNRALRWS | 61 | Q9Y6J9 | |
| KRLLRSDAEAVSTRW | 266 | Q5H9L4 | |
| ESLARLQRAFARKWE | 151 | P49802 | |
| ALKRLSTEEATRWAD | 41 | P57771 | |
| TLFLRAKDEASARSW | 246 | Q13424 | |
| AWLHDSFREELRKLL | 336 | P49683 | |
| SRFEDWLKSAERTAA | 6146 | Q8WXH0 | |
| WATALAEGERDALRR | 76 | O15061 | |
| NWLKARAAERAIAEE | 1601 | Q5JRA6 | |
| SSDFLALAGLRAWRE | 376 | Q8IYG6 | |
| SLVRVDWEIFALLRA | 421 | Q5SWL7 | |
| ISRQSIDALKDWFRD | 1186 | O60841 | |
| ALSDAELGRWAELLS | 1296 | Q9H6K5 | |
| WDTRIAKLRVSADSF | 121 | Q9Y248 | |
| LDSDLWSRLEEKARA | 96 | A6NIN4 | |
| LDWLDAETSRRTKEL | 641 | Q2KHM9 | |
| QRDSKRWSRLEEFDV | 541 | Q96QB1 | |
| SAEELCAWRRTLLES | 1371 | O60287 | |
| ARKAADWLFSADVSR | 586 | Q9UL12 | |
| FADAAEAASWLRERR | 751 | Q9NRC6 | |
| EAAWERLDQAIKART | 3191 | Q9NRC6 | |
| ASLFLTAANRWLEVR | 1236 | Q09428 | |
| VLSWLRRDLEKSTAE | 41 | O75969 | |
| DAALSVAEWLRALHL | 6 | Q96P48 | |
| LVAREKVFWDLAATR | 56 | Q9UBY8 | |
| RSLNLDWIALDADAV | 916 | Q7RTR0 | |
| FDICLARAKERWRSL | 426 | Q9P2M4 | |
| KDRSLLLDWDRVRVF | 251 | O95985 | |
| ERRVASWAVSFERLL | 706 | O14924 | |
| WERAAAVALFNLDIR | 521 | Q9NXC5 | |
| SLALWTFRLLDENSD | 861 | Q0IIM8 | |
| ESEDAELLWRLARAS | 111 | Q96DB5 | |
| LETELADLDAAWRSF | 336 | Q8NDV3 | |
| ELRALWEETSFQLDR | 1006 | O15067 | |
| WSAARRASREAVEKE | 396 | Q86SX3 | |
| LRSWVDTKARPFADL | 731 | Q6ZS81 | |
| EAKLLAAESWTRELE | 686 | O15015 | |
| DLFRALWRSLSREVK | 6 | Q8N183 | |
| WDELARVLVTLFDSR | 1236 | P21359 | |
| EELASKELAAWRRRE | 1016 | Q92576 | |
| EETARTLWALSERLI | 391 | Q9NZC7 | |
| RLRQFSDLWVRLEES | 431 | Q86V40 | |
| RRAELEASRSLWALL | 636 | Q9H254 | |
| AESWARDKERLLEAA | 656 | Q9H254 | |
| AAAAWEERFSSLRRL | 2096 | Q9H254 | |
| AAKLWFLTDRRIRED | 6 | Q9ULI2 | |
| VAAWAVARATLADAR | 291 | P49190 | |
| VARATLADARCWELS | 296 | P49190 | |
| VEFIQEWALLDSARR | 11 | Q96JL9 | |
| ALAEDTEIWFLDRAL | 166 | Q68CL5 | |
| TKLSRREIDSWFSER | 566 | Q9Y6X8 | |
| EFRLVAADRRSWKIL | 21 | Q6NXT4 | |
| LTADRDEKIRVSWAA | 161 | P57081 | |
| VADDRLLRIWALELK | 311 | Q9NYS7 | |
| WSLRNSKEERIDLDA | 561 | P13866 | |
| DLSISDWLARERLRT | 1846 | Q5T5U3 | |
| AFEESLVARDWSRAL | 1416 | Q68DK2 | |
| ASLRSRLALQFVDRW | 1471 | Q68DK2 | |
| SFDVTDTVREWLLRR | 201 | P10600 | |
| WCSILEELRLDADRT | 131 | Q9Y473 | |
| WENFRTLTDLLLRFE | 371 | O76024 | |
| LDLSAKRVAESWAFE | 36 | Q9H7M6 | |
| SRREELWACARTLAL | 746 | Q9H7M6 | |
| LVFWSDVTLDRILRA | 481 | O75096 | |
| LDAERLASAVELWRG | 1301 | Q13459 |